featured
Ranolazine as Secondary Agent in Type 2 Diabetes Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Ranolazine on Glycaemic Control in Patients With Type 2 Diabetes Treated With Either Glimepiride or Metformin
Diabetes Obes Metab 2016 May 01;18(5)463-474, J Pettus, B McNabb, RH Eckel, JS Skyler, A Dhalla, S Guan, P Jochelson, L Belardinelli, RH HenryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.